Brought to you by:
Our past is prologue: We are losing the battle to train more Black doctors
My mother was a child of the 1960s. Despite not having a college degree, she was determined to teach my sister and me that women could do anything. I guess my sister was really the intended target, but I was…
Alucent Biomedical announces first patient enrolled in first-in-human natural vascular scaffolding clinical trial
Alucent Biomedical announced in a press release that it has enrolled the first patient in ACTIVATE II, an Australia-based first-in-human clinical trial to evaluate the safety and efficacy of its natural vascular scaffolding (AlucentNVS) technology. The therapy is designed to open…
Help tell the SVS story through images
Thanks to smartphones, almost everyone usually has a good camera at hand and thousands of digital photos in storage. So get that phone charged and be ready to click the button and capture your lives and specialty, from photos of your…
Interview: SCVS leaders discuss training challenges, position of private practice, diversifying generation of surgeons
Barriers thrown up between the worlds of private or community vascular surgery and academic practice need to be dismantled for the betterment of the specialty at large. At stake are some of the very fundamentals of what makes vascular surgeons…
At VRIC 2022, Clowes lecturer to walk in research footsteps of field progenitor
When Kathleen Martin, PhD, gives the Alexander W. Clowes Distinguished Lecture at the 2022 Vascular Research Initiatives Conference (VRIC) in May, she’ll be discussing research that the late Clowes himself studied. “He’s really the father of this field,” she said. “I’m…
Rare case series shows 100% limb salvage in pediatric bone tumor resections with vascular involvement
A retrospective review of a rare set of pediatric bone tumor resection cases with significant blood vessel involvement has demonstrated 100% limb salvage and 0% local recurrence. The 14-year experience involved 117 cases treated at Louisiana State University (LSU) and…
Interview: JVS group enters new era with brand chief and team-based approach
With changes occurring regularly in the publication business of scientific journals, the Society for Vascular Surgery (SVS) is planning changes with its own Journal of Vascular Surgery (JVS) publications. Effective July 1, Immediate Past President Ronald Dalman, MD, will be…
VAM: How abstracts are selected
The abstracts presented at the Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM) are the result not just of thorough research, but also a meticulous—and blind—selection process. The procedure starts months ahead of the yearly annual meeting, with the…
SVS’ AMA membership push aimed at safeguarding vascular surgery voice on coding issues
The Society for Vascular Surgery (SVS) is urging members to join the American Medical Association (AMA) in a bid to maintain a critical voice in the decision-making process for the specialty. The reason is simple: Unless the percentage of dual…
Shockwave Medical announces global launch of new peripheral IVL catheter
Shockwave Medical has announced the global commercial availability of the Shockwave M5+ peripheral intravascular lithotripsy (IVL) catheter after receiving both Food and Drug Administration (FDA) and CE mark clearance. A company press release details that the Shockwave M5+ catheter is specifically designed to…